Pulmonx OUS Patients

Pulmonx is focused on developing life-changing technologies that improve the lives of patients suffering from lung disease.

Emphysema is a serious disease that leads to shortness of breath and a reduced quality of life. Globally, over 30 million patients have been diagnosed with emphysema.

The Zephyr® Endobronchial Valve is a minimally invasive treatment option for severe emphysema. This simple procedure has been clinically proven to significantly improve lung function, exercise tolerance, and quality of life.

Hear patients share their experience with emphysema and the Zephyr valve.

Italian Case Study

German Case Study